This is the largest early-stage funding in China’s brain computer interface industry.

In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...

A review article just published on the state of clinical trials of implantable brain–computer interfaces (doi.org/njn8). Join the conversation. The global landscape ...

Paradromics announced today that it kicked off a new partnership program to open collaboration on brain-computer interface ...

Neurotechnology company Paradromics will test its device in a trial aimed at safely restoring speech for people with severe motor impairments. Paradromics, a neurotechnology developer, announced today ...

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation, a pioneering brain–computer interface (BCI) company, today announced a clinical research project with Beth Israel ...

The study will evaluate the long-term use of Connexus BCI for its ability to safely restore speech and enable computer control for people with severe motor impairment. AUSTIN, Texas--(BUSINESS ...

Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product. Tech companies are always trying out new ways for people to interact with computers—consider ...

Cognixion has announced a clinical trial that integrates its non-invasive EEG-based brain–computer interface (BCI) technology with the Apple Vision Pro with no surgery required. The aim of the trial ...

Synchron has reported that its miniature brain-computer interface implant, threaded up through the blood vessels to help read the activity of the motor cortex, showed no major side effects in a ...

Science Corp., a biotech startup focused on brain-computer interface technologies, announced Thursday that it has closed on a ...

While Elon Musk’s Neuralink likes to say it’s “pioneering” brain-computer interfaces (BCIs), China’s BCI industry is already quietly moving from research to scale. A new wave of startups is racing to ...